Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Healthpeak Properties Q3 2026 Results: Turns Profitable, Net Income $17.3M

Healthpeak Properties reported total revenues of $820.9 million for the third quarter of 2026, up from $705.9 million in the prior year, driven by a significant increase in resident fees and services. Net income attributable to the company was $17.3 million ($0.02 per share), a recovery from a net loss of $117.1 million in the same period of 2025.

Watch the Healthpeak Properties, Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue820.9705.9
Profit before tax34.265.2
Net income17.3-117.1
EPS (diluted, $ a share)$0.02$-0.17

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+16.3%
Source

10-Q filed with the SEC, NYSE: DOC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Healthpeak Properties, Inc.: key numbers

Share price
$19.46Close, Nov 17
Market cap
$13.4B
Shares outstanding
689.54MLatest SEC cover page
Sector
Real Estate & Construction
Industry
Real Estate Investment TrustsSIC 6798

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Healthpeak Properties, Inc.

All →
6:38 PM ET Form 4
Insider Selling

Healthpeak Properties EVP and Treasurer Ankit B. Patadia Sells $127K of Stock

Ankit B. Patadia, EVP and Treasurer, sold 6,115 shares of Healthpeak Properties, Inc. at $20.78 a share, worth $127K in total on Nov 9, 2026. Shares held after the trade: 2,838 (-68.3%).

Value
$127K
Shares
6,115
Price
$20.78
Role
EVP and Treasurer
Holding change
-68.3%
Trade date
Nov 9, 2026
4:11 PM ET 8-K
Financial Results

Healthpeak Properties Financial Results

Healthpeak Properties reported third quarter 2026 financial results, including net income of $0.02 per share and FFO as Adjusted of $0.44 per share. The company increased its full-year 2026 earnings guidance and highlighted strong leasing activity in its Outpatient Medical and Lab segments, alongside significant acquisition activity in its majority-owned Janus Living subsidiary.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.